Novartis Boosts Immunology Investment with IFM Tre Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 4 (Table of Contents)
Published: 6 Apr-2019
DOI: 10.3833/pdr.v2019.i4.2416 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Novartis has agreed to acquire anti-inflammatory drug specialist, IFM Tre, a subsidiary company of IFM Therapeutics, for up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS